Medicale Corp. Sees Reduced Losses but Faces Liquidity Challenges in Q2 Financial Review

Medicale Corp. (PINK: MCLE) - Q2 Financial Overview

Positive Aspects:

• Decrease in Operating Expenses: Operating expenses for the three months ended March 31, 2025 were $6,269, down 41% from $10,603 in Q2 2024.
• Improvement in Net Loss: The net loss decreased to $8,275 for the three months ended March 31, 2025, compared to $11,564 in the same period last year, reflecting a noteworthy reduction in expenses.

Negative Aspects:

• Accumulated Deficit: The company has an accumulated deficit of $200,800 as of March 31, 2025, which raises concerns regarding its ability to operate as a going concern.
• Cash Position: The cash balance reduced to $0 from $159, indicating a potential liquidity struggle.
• Increased Current Liabilities: Current liabilities grew to $25,932 from $15,507, driven by rising accounts payable and accrued interest.

Key Statistics:

• Current Assets: $0
• Current Liabilities: $25,932
• Net Loss for Six Months: $24,955, down from $30,871 in 2024.
• Weighted Average Shares Outstanding: 5,920,000

Medicale Corp.'s financial indicators reflect a company in a transitional phase, with notable reductions in expenses but facing challenges with accumulated losses and cash position. Continuous monitoring and potential investment will be essential for its sustainability and growth.